|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/25/21 Petmed Express Inc. 10-K 3/31/21 67:5.5M RDG Filings/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 744K
2: EX-21.1 Subsidiaries List HTML 19K
3: EX-23.1 Consent of Expert or Counsel HTML 19K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 20K
13: R1 Document And Entity Information HTML 79K
14: R2 Consolidated Balance Sheets HTML 98K
15: R3 Consolidated Balance Sheets (Parentheticals) HTML 41K
16: R4 Consolidated Statements of Income HTML 91K
17: R5 Consolidated Statements of Changes in HTML 58K
Shareholders' Equity
18: R6 Consolidated Statements of Cash Flows HTML 90K
19: R7 Note 1 - Summary of Significant Accounting HTML 98K
Policies
20: R8 Note 2 - Property and Equipment HTML 37K
21: R9 Note 3 - Valuation and Qualifying Accounts HTML 32K
22: R10 Note 4 - Accrued Expenses and Other Current HTML 35K
Liabilities
23: R11 Note 5 - Income Taxes HTML 64K
24: R12 Note 6 - Shareholders' Equity HTML 35K
25: R13 Note 7 - Restricted Stock HTML 37K
26: R14 Note 8 - Fair Value Measurements HTML 26K
27: R15 Note 9 - Net Income Per Share HTML 41K
28: R16 Note 10 - Commitments and Contingencies HTML 29K
29: R17 Note 11 - Employee Benefit Plan HTML 24K
30: R18 Note 12 - COVID-19 HTML 24K
31: R19 Note 13 - Related Party Transaction HTML 24K
32: R20 Note 14 - Subsequent Events HTML 23K
33: R21 Note 15 - Quarterly Financial Data (Unaudited) HTML 53K
34: R22 Significant Accounting Policies (Policies) HTML 133K
35: R23 Note 1 - Summary of Significant Accounting HTML 70K
Policies (Tables)
36: R24 Note 2 - Property and Equipment (Tables) HTML 36K
37: R25 Note 3 - Valuation and Qualifying Accounts HTML 31K
(Tables)
38: R26 Note 4 - Accrued Expenses and Other Current HTML 34K
Liabilities (Tables)
39: R27 Note 5 - Income Taxes (Tables) HTML 64K
40: R28 Note 6 - Shareholders' Equity (Tables) HTML 28K
41: R29 Note 7 - Restricted Stock (Tables) HTML 31K
42: R30 Note 9 - Net Income Per Share (Tables) HTML 39K
43: R31 Note 15 - Quarterly Financial Data (Unaudited) HTML 51K
(Tables)
44: R32 Note 1 - Summary of Significant Accounting HTML 42K
Policies (Details Textual)
45: R33 Note 1 - Summary of Significant Accounting HTML 48K
Policies - Disaggregation of Revenue by Type
(Details)
46: R34 Note 2 - Property and Equipment - Major HTML 35K
Classifications of Property and Equipment
(Details)
47: R35 Note 3 - Valuation and Qualifying Accounts - HTML 25K
Activity in the Valuation and Qualifying Accounts
(Details)
48: R36 Note 4 - Accrued Expenses and Other Current HTML 42K
Liabilities - Major Classifications of Accrued
Expenses and Other Current Liabilities (Details)
49: R37 Note 5 - Income Taxes (Details Textual) HTML 27K
50: R38 Note 5 - Income Taxes - Deferred Income Taxes HTML 35K
(Details)
51: R39 Note 5 - Income Taxes - Components of Income Tax HTML 41K
Provision (Details)
52: R40 Note 5 - Income Taxes - Reconciliation of Income HTML 32K
Tax Provision (Details)
53: R41 Note 6 - Shareholders' Equity (Details Textual) HTML 55K
54: R42 Note 6 - Shareholder's Equity - Declared Dividends HTML 41K
(Details)
55: R43 Note 7 - Restricted Stock (Details Textual) HTML 58K
56: R44 Note 7 - Restricted Stock - Non-vested Restricted HTML 34K
Stock (Details)
57: R45 Note 9 - Net Income Per Share (Details Textual) HTML 20K
58: R46 Note 9 - Net Income Per Share - Basic and Diluted HTML 57K
Net Income Per Share (Details)
59: R47 Note 10 - Commitments and Contingencies (Details HTML 53K
Textual)
60: R48 Note 11 - Employee Benefit Plan (Details Textual) HTML 24K
61: R49 Note 13 - Related Party Transaction (Details HTML 26K
Textual)
62: R50 Note 14 - Subsequent Events (Details Textual) HTML 30K
63: R51 Note 15 - Quarterly Financial Data (Unaudited) - HTML 47K
Summarized Unaudited Quarterly Financial Data
(Details)
65: XML IDEA XML File -- Filing Summary XML 120K
12: XML XBRL Instance -- pets20210331_10k_htm XML 1.14M
64: EXCEL IDEA Workbook of Financial Reports XLSX 61K
8: EX-101.CAL XBRL Calculations -- pets-20210331_cal XML 121K
9: EX-101.DEF XBRL Definitions -- pets-20210331_def XML 829K
10: EX-101.LAB XBRL Labels -- pets-20210331_lab XML 700K
11: EX-101.PRE XBRL Presentations -- pets-20210331_pre XML 873K
7: EX-101.SCH XBRL Schema -- pets-20210331 XSD 135K
66: JSON XBRL Instance as JSON Data -- MetaLinks 264± 411K
67: ZIP XBRL Zipped Folder -- 0001437749-21-013213-xbrl Zip 216K
Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Menderes Akdag, certify that:
|
1. |
I have reviewed this Annual Report on Form 10-K of PetMed Express, Inc. for the fiscal year ended March 31, 2021; |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5. |
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of the internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions): |
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
By: /s/ Menderes Akdag Chief Executive Officer and President |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/25/21 | 3, 8-K | ||
| For Period end: | 3/31/21 | |||
| List all Filings | ||||